Article Information
History
- December 6, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Shafeeq A. Mohammed, PhD1,
- Era Gorica, PhD1,
- Mattia Albiero, PhD2,3,
- Gergely Karsai, PhD4,
- Alessandro Mengozzi, MD PhD1,5,6,
- Carlo Maria Caravaggi, MD7,
- Samuele Ambrosini, PhD1,
- Stefano Masi, MD PhD5,8,
- Maria Cristina Vinci, PhD9,
- Gaia Spinetti, PhD10,
- Sanjay Rajagopalan, MD11,12,
- Assam El-Osta, PhD13,14,15,
- Jaroslav Pelisek16,
- Frank Ruschitzka, MD1,17,
- Gian Paolo Fadini, MD PhD2,3,
- Sarah Costantino, PhD1,17,§ and
- Francesco Paneni, MD PhD1,17,*,§
- 1Center for Translational and Experimental Cardiology (CTEC), Department of Cardiology, Zurich University Hospital and University of Zürich, Wagistrasse 12, Schlieren CH-8952, Switzerland
- 2Department of Surgery, Oncology and Gastroenterology - University of Padova, Italy
- 3Veneto Institute of Molecular Medicine, Padova, Italy
- 4Institute of Clinical Chemistry, University Hospital Zurich, University of Zurich, Zurich-8091, Switzerland
- 5Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
- 6Health Science Interdisciplinary Center, Sant’Anna School of Advanced Studies, Pisa, Italy;
- 7Diabetic Foot Department, IRCCS MultiMedica, Milan, Italy
- 8Institute of Cardiovascular Science, University College London, London, UK
- 9Unit of Vascular Biology and Regenerative Medicine, Centro Cardiologico Monzino IRCCS, 20138 Milan, Italy
- 10Cardiovascular Pathophysiology-Regenerative Medicine Laboratory, IRCCS MultiMedica, Milan, Italy
- 11Harrington Heart and Vascular Institute, University Hospitals, Cleveland, OH
- 12Case Western Reserve University School of Medicine, Cardiovascular Research Institute, Cleveland, OH
- 13Baker Heart and Diabetes Institute, Epigenetics in Human Health and Disease Program, Melbourne, Vic, Australia;
- 14Department of Diabetes, Central Clinical School, Monash University, Melbourne, Vic, Australia;
- 15University College Copenhagen, Faculty of Health, Department of Technology, Biomedical Laboratory Science, Copenhagen, Denmark;
- 16Department of Vascular Surgery, University Hospital Zurich, 8091 Zurich, Switzerland;
- 17University Heart Center, Cardiology, University Hospital Zurich, Zürich, Switzerland
- ↵*Address for Correspondence:
Prof. Dr. med. Francesco Paneni, FESC Director, Center for Translational and Experimental Cardiology (CTEC) Head, Cardiometabolic Division University Heart Center Department of Cardiology Rämistrasse 100 CH-8091 Zürich francesco.paneni{at}uzh.ch www.herzzentrum.usz.ch
↵§ The authors contributed equally to this work.
Posted December 06, 2023.
Targeting the Histone Methyltransferase SETD7 Rescues Diabetes-induced Impairment of Angiogenic Response by Transcriptional Repression of Semaphorin 3G
